Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib

Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue

(2015) Wei Luo et al.   Oncotarget

Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate

(2013) Alejandro S. Godoy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design

(2013) Javier Blanc et al.   Anti-Cancer Agents in Medicinal Chemistry

Cytotoxic Properties of Sunitinib and Sorafenib on Human Corneal Epithelial Cells

(2013) Tarek Bayyoud et al.   CURRENT EYE RESEARCH

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer

(2013) M. Dror Michaelson et al.   JOURNAL OF CLINICAL ONCOLOGY

State of the art paper Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option?

(2012) Magdalena Zaborowska et al.   Archives of Medical Science

Angiogenesis in prostate cancer: onset, progression and imaging

(2012) Giovanna Russo et al.   BJU INTERNATIONAL

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

In Vivo, In VitroToxicity andIn VitroAngiogenic Inhibition of Sunitinib Malate

(2012) Eduardo Dib et al.   CURRENT EYE RESEARCH

Anti-angiogenic therapies in prostate cancer

(2012) José María Martínez-Jabaloyas et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Targeting angiogenesis for the treatment of prostate cancer

(2012) Emmanuel S Antonarakis et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

(2012) P Kharaziha et al.   Cell Death & Disease

Tumor endothelial cells have features of adult stem cells

(2011) Andrew C. Dudley et al.   CELL CYCLE

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

(2011) M. S. Anglesio et al.   CLINICAL CANCER RESEARCH

Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

(2011) Daniel Castellano et al.   EXPERT OPINION ON PHARMACOTHERAPY

Tumor exploits alternative strategies to achieve vascularization

(2011) Benedetta Bussolati et al.   FASEB JOURNAL

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer

(2011) Emma K. Beardsley et al.   INVESTIGATIONAL NEW DRUGS

Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors

(2010) M B Nilsson et al.   ONCOGENE

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

(2009) G. Sonpavde et al.   ANNALS OF ONCOLOGY

Phase II study of sunitinib in men with advanced prostate cancer

(2009) M. Dror Michaelson et al.   ANNALS OF ONCOLOGY

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer

(2009) Jeanny B. Aragon-Ching et al.   BJU INTERNATIONAL

Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells

(2009) Y.-Q. Xiong et al.   CLINICAL CANCER RESEARCH

Calcification of Multipotent Prostate Tumor Endothelium

(2008) Andrew C. Dudley et al.   CANCER CELL

Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies

(2008) Kyoko Hida et al.   CANCER SCIENCE

A Phase II Clinical Trial of Sorafenib in Androgen-Independent Prostate Cancer

(2008) W. L. Dahut et al.   CLINICAL CANCER RESEARCH

Androgen Receptor Is Causally Involved in the Homeostasis of the Human Prostate Endothelial Cell

(2008) Alejandro Godoy et al.   ENDOCRINOLOGY